Accenture has published its annual Technology vision survey which had one responses from executives across various industries. The results showed that 70% of the life science executives surveyed believe that the next generation of digital health platforms would be commanded by healthcare and life sciences companies instead of technology companies. 85% hold that the life science sector is also expected to transition from a product-based industry to an outcomes-based more than 1,000, with pharmaceutical companies already beginning to move towards remote monitoring packages sold alongside their drug products.
Accenture has published its annual Technology vision survey which had more than 1,000 responses from executives across various industries. The results showed that 70% of the life science executives surveyed believe that the next generation of digital health platforms would be commanded by healthcare and life sciences companies instead of technology companies. 85% hold that the life science sector is also expected to transition from a product-based industry to an outcomes-based one, with pharmaceutical companies already beginning to move towards remote monitoring packages sold alongside their drug products.